¿Por qué aumenta el cáncer de colon entre los jóvenes? JAMA Oncology liga el exceso de ultraprocesados a un 45% más de adenomas antes de 50; contexto español y medidas útiles para reducir riesgo. La nueva investigación publicada en JAMA Oncology refuerza ...

¿Por qué aumenta el cáncer de colon entre los jóvenes? #Ultraprocesados #CáncerDeColon #Salud #Nutrición #Oncología #Prevención #España #JAMAOncology #Cribado #DietaMediterránea #Microbiota #15denoviembre #felizsabado

donporque.com/por-que-aume...

Emerging Artificial Intelligence Technologies for Risk Assessment and Management in Acute Myeloid Leukemia: A Nov 06, 2025 MedicalScholarlyArticle by Mohammad Amin Ansarian, MBBS

This review examines the use of artificial intelligence in managing acute myeloid leukemia. #JAMAOncology

Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data Aug 21, 2025 MedicalScholarlyArticle by Robert C. Grant, MD, PhD

This prognostic study characterizes the incidence of chronic kidney disease after cisplatin treatment and evaluates prediction models. #JAMAOncology

The Role of Social Media in Fueling Bias in Oncology Apr 24, 2025 MedicalScholarlyArticle by Raffaele Giusti, MD

This Viewpoint explores the role of social media in the dissemination of medical research findings and discusses how oversight, education, and media literacy can help prevent the spread of misinformation. #JAMAOncology

Patient-Centered Research Through Artificial Intelligence to Identify Priorities in Cancer Care Apr 24, 2025 MedicalScholarlyArticle by Jiyeong Kim, PhD, MPH

This case series uses artificial intelligence and natural language processing to analyze a large dataset of patient messages to inform patient-centered research, counseling, and quality improvement initiatives in cancer care. #JAMAOncology

Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer Dec 26, 2024 Article by Mehrdad Rakaee, PhD

This multicenter cohort study develops and assesses the validity of a deep learning model for predicting immune checkpoint inhibitor response in patients with advanced non−small cell lung cancer. #JAMAOncology

Bishal Gyawali: The case of cancer drug Xtandi - OncoDaily Bishal Gyawali: The case of cancer drug Xtandi / Aaron S. Kesselheim, Bishal Gyawali, cancer, Cancer Policy, Emily H. Jung, Helen Mooney, JAMA Oncology, Jerry

The case of cancer drug Xtandi - Bishal Gyawali
@akesselheim.bsky.social
@jama.com

oncodaily.com/science/bish...

#Cancer #CancerPolicy #JAMAOncology #OncoDaily #Oncology #Xtandi

Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer. #JAMAOncology

Open Access
jamanetwork.com/journals/jam...

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Mar 01, 2022 Article by Global Burden of Disease 2019 Cancer Collaboration

The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 examines cancer burden and trends globally for 204 countries and territories and by Socio-demographic Index quintiles from 2010 to 2019. #JAMAOncology